Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals With Type 2 Diabetes
Launched by TRACY JALBUENA MD · Sep 14, 2022
Trial Information
Current as of August 11, 2025
Withdrawn
Keywords
ClinConnect Summary
Effect of Remote Patient Monitoring and Patient Education on Patient Activation and Glycemic Control in Individuals with Type 2 Diabetes
Summary
ABSTRACT
In 2021, the MaineHealth Telehealth team was awarded a five-year, $1.7 million "Evidence-Based Telehealth Network Program" grant (EB TNPG) from Health Resources and Services Administration (HRSA). This grant is aimed at improving patient access to educational and management services for patients with type 2 diabetes in the rural Maine primary care setting by implementing RPM. The RPM devices will be used to transmit a participant's home...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be enrolled in Living Well with Diabetes education program
- • Have an HbA1c% ≥ 8 in the prior 6 months
- • Be capable of providing consent
- • Be adults (age 18 or over)
- Exclusion Criteria:
- • Primarily managed by endocrinology for their diabetes (\> 1 visit with endocrinology in the previous 12 months)
- • Incarcerated
- • PCP not at one of the 30 primary care practices listed (see attachment List of PCP Practices)
- • Diagnosed with type 1 diabetes
- • Candidate for continuous glucose monitoring, as defined by Centers for Medicare and Medicaid Services as using at least three insulin injections per day, any combination of types of insulins
- • Pregnant
- • Have previously participated in the Living Well with Diabetes/Virtual Diabetes Self-Management Program
- • Have previously used a remote patient monitoring device for diabetes management
- • Have a diagnosis of dementia or other clinical diagnosis that would impair participation capacity
- • Currently participating in any other clinical trial regarding diabetes care or management
- • Currently enrolled in hospice
- • Currently residing in a long term care or rehabilitation facility
About Tracy Jalbuena Md
Dr. Tracy Jalbuena, MD, is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical practice and a focus on innovative therapeutic approaches, Dr. Jalbuena leads trials that address critical health challenges. Her expertise encompasses various therapeutic areas, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, Dr. Jalbuena aims to drive meaningful advancements in healthcare, ultimately translating research findings into practical treatments for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rockport, Maine, United States
Patients applied
Trial Officials
Tracy Jalbuena, MD
Principal Investigator
MaineHealth
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials